Soft tissue sarcomas are tumours that arise from connective tissue, fat, muscle, and blood vessels. They are distinct from epithelial malignancies (carcinomas) in both morphology and behaviour. Unfortunately, due to their rare occurrence, these tumours can be mistaken clinically and pathologically which affects patients management and prognosis.

As part of sarcoma awareness month, we are doing a series on soft tissue sarcomas as well as bone sarcoma in conjunction with the Australian & New Zealand Sarcoma Association to raise awareness and help provide education about these diagnoses.

This is the story of soft tissue sarcoma (part 1).

Useful links:

Australia and New Zealand Sarcoma Association: https://sarcoma.org.au/

Find a sarcoma specialist: https://sarcoma.org.au/pages/about-sarcoma/find-a-sarcoma-specialist

Sarcoma guidelines: https://sarcoma.org.au/pages/sarcoma-guidelines

Seeking a second opinion: https://sarcoma.org.au/pages/about-sarcoma/seeking-second-opinion

Useful patient information: https://sarcoma.org.au/pages/about-sarcoma/patient-and-carer-sarcoma-information

Article from the RCPA about reviewing soft tissue tumours and obtaining second opinions: https://pubmed.ncbi.nlm.nih.gov/41390329/

Our Special Guests:

Associate Professor Richard Boyle who is an orthopaedic oncologist and surgeon who specialises in the bone and soft tissue sarcoma.

Professor Fiona Maclean is an anatomical pathologist who specialises in soft tissue pathology and clinical professor at Macquarie University.

Listen:

This Medical Life podcast is available on all podcasting services and Spotify. Members of the RACGP are able to log the hours as CPD (Education) that they listen to the episodes under self record via Quick log. We invite you to help support us on our donation page.

See omnystudio.com/listener for privacy information.

Ethics, codes of conduct, and challenging decisions are universal constants in medicine. Difficult situations and trying to do the right thing are not always obvious particularly when these decisions involve lots of emotions, family members, and have life and death implications. Ethics, and ethics committees, can help to provide a clear and consensus path for clinicians, patients, and family members. We discuss the role ethics and ethics committees have in modern medicine with our special guest.

This is the story of clinical ethics.

Useful links:

Free critical thinking course through UQ school of philosophy

Clinical Ethics Society of Australasia – Great organisation focusing on clinical ethics, with affordable membership and lots of access to resources. They run an excellent ‘ethics intensive’ and yearly symposium as well as other masterclasses throughout the year.

Australasian Association of Bioethics and Health Law – Major organisation for ethics and health law. Excellent conference each year.

Links to Dr Melanie Jansen’s poetry

Instragram: @drmelaniejansen_poetry

Dr Melanie Jansen’s debut poetry collection, All That Could Be Lost, is available online from 5 Islands Press and at independent bookstores.

Our Special Guest:

Dr Melanie Jansen who is a clinical ethicist and paediatric intensive care consultant

Listen:

This Medical Life podcast is available on all podcasting services and Spotify. Members of the RACGP are able to log the hours as CPD (Education) that they listen to the episodes under self record via Quick log. We invite you to help support us on our donation page.

See omnystudio.com/listener for privacy information.

Lipoprotein (a) (Lp(a)) was discovered in 1963 by a Norwegian geneticist by the name of Kåre Berg who studied particles that carried cholesterol in the blood. He found some patients had an additional protein on the low-density lipoprotein. Studies found that patients with elevated Lp(a) had increased risks of cardiovascular disease. However, the levels were not affected by diet, environmental factors, or medications. The result is that this test was largely ignored for the last few decades.

Recent dyslipidaemia guidelines released by the United States and Europe have returned a focus back on to Lp(a). They recommend that patients should have Lp(a) tested once throughout their life to assess their cardiovascular disease risk. The result can help identify which patients are at a higher risk of cardiovascular morbidity and mortality and who will benefit from lifestyle modification and early intervention.

This resource is referenced during the discussion: https://www.lpaclinicalguidance.com/

This is the story of lipoprotein (a).

Our Special Guests:

Dr Michael Page is a chemical pathologist at Clinipath in Perth, senior lecturer at the UWA Medical School, and immediate past President of the AMA (WA).

Listen:

This Medical Life podcast is available on all podcasting services and Spotify. Members of the RACGP are able to log the hours as CPD (Education) that they listen to the episodes under self record via Quick log. We invite you to help support us on our donation page.

See omnystudio.com/listener for privacy information.